Corticosteroid therapy induces clinical, laboratory and histological improvements in 80% of patients with autoimmune hepatitis. Prednisone, alone or at a lower dose in combination with ...

or prominent changes suggestive of another disease Interface hepatitis, moderate to severe No biliary lesions, granulomas, or prominent changes suggestive of another disease AIH = autoimmune ...

Mild changes in liver function are somewhat common in the postpartum period. This may be related to changes in the immune system. Postpartum clinical symptoms associated with hepatitis B are rare.

Research analyzing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...

Gut microbiota-targeted therapies, biologics, and immune-modulating drugs like IL-2 and Tregs hold great potential. Tailoring treatment to individual patient needs remains essential in managing ...

New research from the University of Missouri School of Medicine indicates that accidental opioid overdose patients in central Missouri have high rates of hepatitis C infections, despite only 40% of ...

The aim of this study was to take advantage of a large well-defined corticosteroids treatment-naïve group of patients with autoimmune hepatitis (AIH) to rigorously characterise gut dysbiosis compared ...

Background: Antibodies to soluble liver antigen/liver pancreas (SLA/LP) are specific markers of autoimmune hepatitis. Their target antigen has recently been cloned. Aims: To establish standardised ...

The hepatitis E virus affects the liver. But infected liver cells secrete a viral protein that reacts with antibodies in the ...

Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis ...

Research analysing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...